A Randomized Clinical Trial of Saccharomyces Cerevisiae Versus Placebo in the Irritable Bowel Syndrome

α
Dr. Amjad Atef Suliman Alhelo
Dr. Amjad Atef Suliman Alhelo

Send Message

To: Author

A Randomized Clinical Trial of Saccharomyces Cerevisiae Versus Placebo in the Irritable Bowel Syndrome

Article Fingerprint

ReserarchID

1973J

A Randomized Clinical Trial of Saccharomyces Cerevisiae Versus Placebo in the Irritable Bowel Syndrome Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

References

15 Cites in Article
  1. Tadataka Yamada Irritable bowel syndrome, Textbook of gastroenterology.
  2. Ashton Harper,Malwina Naghibi,Davinder Garcha (2018). The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome.
  3. Mark Pimentel,Evelyn Chow,Henry Lin (2000). Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome.
  4. Amélie Cayzeele-Decherf,Fanny Pélerin,Sébastien Leuillet,Benoit Douillard,Béatrice Housez,Murielle Cazaubiel,Gunnard Jacobson,Peter Jüsten,Pierre Desreumaux (2017). <i>Saccharomyces cerevisiae</i>CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.
  5. G Parkes,J Sanderson,K Whelan (2010). Treating irritable bowel syndrome with probiotics: the evidence.
  6. Guillaume Pineton De Chambrun,Christel (2015). A randomized clinical trial of saccharomyces cerevisiae versus placebo in the irritable bowel syndrome.
  7. Quigley Em,Ohman (2012). The microbiota link to irritable bowel Syndrome: an emerging story Jeffery.
  8. Collins Sm (2014). A role for the gut microbiota in ibs, Nature reviews gastroenterology & hepatology.
  9. M1 Camilleri,M Choi (1997). Review article: irritable bowel syndrome.
  10. Lr1 Krogsgaard,Al2 Engsbro,P Bytzer (2013). Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort.
  11. (2017). UpToDate®.
  12. (2017). Treatment of irritable bowel syndrome in adults.
  13. Daryn Michael (2017). Can taking probiotics improve well-being in females suffering from irritable bowel syndrome?.
  14. Tanisa Patcharatrakul,Kessarin Thanapirom,Sutep Gonlachanvit (2017). Application of Rome III vs. Rome IV Diagnostic Criteria for Irritable Bowel Syndrome (IBS) in Clinical Practice: is the Newer the Better?.
  15. Binrui Chen (2017). Reduced interstitial cells of Cajal density and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Dr. Amjad Atef Suliman Alhelo. 2019. \u201cA Randomized Clinical Trial of Saccharomyces Cerevisiae Versus Placebo in the Irritable Bowel Syndrome\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 19 (GJMR Volume 19 Issue F2): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-F Classification: NLMC Code: WI 420
Version of record

v1.2

Issue date

March 15, 2019

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 2795
Total Downloads: 1343
2026 Trends
Related Research

Published Article

Abstract not found

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

A Randomized Clinical Trial of Saccharomyces Cerevisiae Versus Placebo in the Irritable Bowel Syndrome

Dr. Amjad Atef Suliman Alhelo
Dr. Amjad Atef Suliman Alhelo

Research Journals